These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 3924437

  • 1. Coronary thrombolysis in dogs with intravenously administered human pro-urokinase.
    Collen D, Stump D, van de Werf F, Jang IK, Nobuhara M, Lijnen HR.
    Circulation; 1985 Aug; 72(2):384-8. PubMed ID: 3924437
    [Abstract] [Full Text] [Related]

  • 2. Thrombolysis with recombinant human single-chain urokinase-type plasminogen activator (rscu-PA): dose-response in dogs with coronary artery thrombosis.
    Van de Werf F, Jang IK, Collen D.
    J Cardiovasc Pharmacol; 1987 Jan; 9(1):91-3. PubMed ID: 2434801
    [Abstract] [Full Text] [Related]

  • 3. Coronary thrombolysis with intravenously administered human tissue-type plasminogen activator produced by recombinant DNA technology.
    Van de Werf F, Bergmann SR, Fox KA, de Geest H, Hoyng CF, Sobel BE, Collen D.
    Circulation; 1984 Mar; 69(3):605-10. PubMed ID: 6362907
    [Abstract] [Full Text] [Related]

  • 4. Recombinant single-chain urokinase-type plasminogen activator (rscu-PA) induces thrombolysis and systemic fibrinolysis in a canine model of coronary artery thrombosis.
    Söhngen W, Mickelson JK, Simpson PJ, Lucchesi BR.
    Thromb Res; 1988 Jul 01; 51(1):63-74. PubMed ID: 3137691
    [Abstract] [Full Text] [Related]

  • 5. Enhancement of coronary thrombolysis with plasminogen pro-activator by pretreatment with heparin.
    Susawa T, Yui Y, Hattori R, Takatsu Y, Yui N, Takahashi M, Aoyama T, Murohara Y, Shirotani M, Kawai C.
    Jpn Circ J; 1988 Jan 01; 52(1):72-8. PubMed ID: 3129601
    [Abstract] [Full Text] [Related]

  • 6. Synergistic combinations of recombinant human tissue-type plasminogen activator and human single-chain urokinase-type plasminogen activator. Effect on thrombolysis and reocclusion in a canine coronary artery thrombosis model with high-grade stenosis.
    Ziskind AA, Gold HK, Yasuda T, Kanke M, Guerrero JL, Fallon JT, Saito T, Collen D.
    Circulation; 1989 Feb 01; 79(2):393-9. PubMed ID: 2492455
    [Abstract] [Full Text] [Related]

  • 7. Coronary thrombolysis by intravenous infusion of recombinant single chain urokinase-type plasminogen activator or recombinant urokinase in baboons: effect on regional blood flow, infarct size and hemostasis.
    Flameng W, Vanhaecke J, Stump DC, Van de Werf F, Holmes W, Guenzler WA, Flohe L, Collen D.
    J Am Coll Cardiol; 1986 Jul 01; 8(1):118-24. PubMed ID: 3086416
    [Abstract] [Full Text] [Related]

  • 8. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.
    Matsuo O, Rijken DC, Collen D.
    Thromb Haemost; 1981 Jun 30; 45(3):225-9. PubMed ID: 7025339
    [Abstract] [Full Text] [Related]

  • 9. Thrombolysis with human extrinsic (tissue-type) plasminogen activator in rabbits with experimental jugular vein thrombosis. Effect of molecular form and dose of activator, age of the thrombus, and route of administration.
    Collen D, Stassen JM, Verstraete M.
    J Clin Invest; 1983 Feb 30; 71(2):368-76. PubMed ID: 6681615
    [Abstract] [Full Text] [Related]

  • 10. Coronary thrombolysis with recombinant human tissue-type plasminogen activator.
    Gold HK, Fallon JT, Yasuda T, Leinbach RC, Khaw BA, Newell JB, Guerrero JL, Vislosky FM, Hoyng CF, Grossbard E.
    Circulation; 1984 Oct 30; 70(4):700-7. PubMed ID: 6541103
    [Abstract] [Full Text] [Related]

  • 11. Heparin requirement in tissue-type plasminogen activator-induced experimental coronary thrombolysis: comparison with urokinase-induced coronary thrombolysis.
    Susawa T, Yui Y, Hattori R, Takahashi M, Aoyama T, Takatsu Y, Sakaguchi K, Yui N, Kawai C.
    Jpn Circ J; 1987 Apr 30; 51(4):431-5. PubMed ID: 2441082
    [Abstract] [Full Text] [Related]

  • 12. The effect of intravenous infusion of urokinase on coronary artery thrombolysis in the dog.
    Isojima K, Sato Y, Lew A, Ganz W.
    Jpn Circ J; 1985 Nov 30; 49(11):1195-200. PubMed ID: 4094039
    [Abstract] [Full Text] [Related]

  • 13. Effects of pro-urokinase and urokinase on the fibrinolytic system in man.
    Trübestein G, Popov S, Wolf H, Welzel D.
    Haemostasis; 1987 Nov 30; 17(4):238-44. PubMed ID: 2442078
    [Abstract] [Full Text] [Related]

  • 14. Thrombolysis with human extrinsic (tissue-type) plasminogen activator in dogs with femoral vein thrombosis.
    Korninger C, Matsuo O, Suy R, Stassen JM, Collen D.
    J Clin Invest; 1982 Mar 30; 69(3):573-80. PubMed ID: 7199539
    [Abstract] [Full Text] [Related]

  • 15. Vasodilation, fibrinolysis, and thrombolysis with intraarterial infusion of urokinase in the canine superior mesenteric artery.
    Gurll N, Zinner MJ, Turtinen L, Reynolds DG.
    Gastroenterology; 1978 Sep 30; 75(3):425-31. PubMed ID: 98390
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of intravenous prourokinase and a combination of prourokinase and urokinase in acute myocardial infarction.
    Bode C, Schoenermark S, Schuler G, Zimmermann R, Schwarz F, Kuebler W.
    Am J Cardiol; 1988 May 01; 61(13):971-4. PubMed ID: 2452564
    [Abstract] [Full Text] [Related]

  • 17. Coronary thrombolysis with human single-chain, urokinase-type plasminogen activator (pro-urokinase) in patients with acute myocardial infarction.
    Van de Werf F, Nobuhara M, Collen D.
    Ann Intern Med; 1986 Mar 01; 104(3):345-8. PubMed ID: 3080936
    [Abstract] [Full Text] [Related]

  • 18. Coronary thrombolysis with recombinant single-chain urokinase-type plasminogen activator in patients with acute myocardial infarction.
    Van de Werf F, Vanhaecke J, de Geest H, Verstraete M, Collen D.
    Circulation; 1986 Nov 01; 74(5):1066-70. PubMed ID: 2429783
    [Abstract] [Full Text] [Related]

  • 19. Coronary thrombolysis with tissue-type plasminogen activator in patients with evolving myocardial infarction.
    Van de Werf F, Ludbrook PA, Bergmann SR, Tiefenbrunn AJ, Fox KA, de Geest H, Verstraete M, Collen D, Sobel BE.
    N Engl J Med; 1984 Mar 08; 310(10):609-13. PubMed ID: 6537987
    [Abstract] [Full Text] [Related]

  • 20. Nonradical excited oxygen species induce selective thrombolysis in vivo.
    Stief TW.
    Thromb Res; 1991 May 01; 62(3):147-63. PubMed ID: 1716380
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.